000 | 01873 a2200517 4500 | ||
---|---|---|---|
005 | 20250516180818.0 | ||
264 | 0 | _c20140710 | |
008 | 201407s 0 0 eng d | ||
022 | _a1872-9614 | ||
024 | 7 |
_a10.1016/j.nucmedbio.2013.09.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPickhard, Anja | |
245 | 0 | 0 |
_a²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells. _h[electronic resource] |
260 |
_bNuclear medicine and biology _cJan 2014 |
||
300 |
_a68-76 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAlpha Particles _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aApoptosis _xradiation effects |
650 | 0 | 4 |
_aBismuth _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xpathology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aErbB Receptors _ximmunology |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xradiation effects |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xpathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoconjugates _xtherapeutic use |
650 | 0 | 4 | _aLinear Energy Transfer |
650 | 0 | 4 | _aRadioimmunotherapy |
650 | 0 | 4 |
_aRadioisotopes _xtherapeutic use |
650 | 0 | 4 |
_aSignal Transduction _xradiation effects |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aX-Ray Therapy |
700 | 1 | _aPiontek, Guido | |
700 | 1 | _aSeidl, Christof | |
700 | 1 | _aKopping, Samuel | |
700 | 1 | _aBlechert, Birgit | |
700 | 1 | _aMißlbeck, Martin | |
700 | 1 | _aBrockhoff, Gero | |
700 | 1 | _aBruchertseifer, Frank | |
700 | 1 | _aMorgenstern, Alfred | |
700 | 1 | _aEssler, Markus | |
773 | 0 |
_tNuclear medicine and biology _gvol. 41 _gno. 1 _gp. 68-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nucmedbio.2013.09.010 _zAvailable from publisher's website |
999 |
_c23247125 _d23247125 |